TrueVision 3D Surgical announces agreement with Lensar, collaboration with Leica Microsystems

Article

TrueVision 3D Surgical and Lensar Inc. recently announced a global co-development and distribution agreement that integrates TrueVision’s TrueGuide system into the Lensar Laser System’s technology suite.

Orlando, FL-TrueVision 3D Surgical and Lensar Inc. recently announced a global co-development and distribution agreement that integrates TrueVision’s TrueGuide system into the Lensar Laser System’s technology suite.  

Lensar’s augmented reality imaging technology rotates around the eye and takes scanning images at multiple angles to locate and identify the relevant ocular surfaces, measuring them, and capturing exact biometric data. This information is then used to create a 3D model of the anterior anatomy to help guide customized treatment and precise laser placement of each laser pulse.

In related news, TrueVision 3D Surgical and Leica Microsystems recently announced that Leica will incorporate key components of TrueVision’s 3D intelligent digital visualization and guidance platform into selected Leica Microsystems surgical products under the Leica brand. In addition to co-marketing the Leica and 3D by TrueVision products, the 2 companies will collaborate on projects that will further integrate their respective optical and digital technologies to improve microsurgery outcomes in ophthalmology and neurosurgery.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.